Bayer Collaborates with GeneData, Becomes First Customer for New System

BASEL, Switzerland--GeneData, a privately-held bioinformatics company based here, has announced the release of GD Phylosopher, a functional genomics-based target identification system that it developed with the help of Bayer's pharmaceutical anti-infectives research unit, which is also the first user of the product. Applied to microbial genomes, the system identifies novel targets for next-generation antibiotics. GD Phylosopher is an automated, high-throughput system for gene function prediction and elucidation of essential biochemical pathways from complete genomes.